Does Carboplatin Rapid Desensitization Change Its Adverse Drug Reactions Other than Hypersensitivity and Efficacy in Patients With Ovarian Cancer?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does Carboplatin Rapid Desensitization Change Its Adverse Drug Reactions Other than Hypersensitivity and Efficacy in Patients With Ovarian Cancer?

Published:2020 Issue:6 Volume:12 Page:1046
ISSN:2092-7355
Container-title:Allergy, Asthma & Immunology Research
language:en
Short-container-title:Allergy Asthma Immunol Res

Author:

Park Han-Ki¹^ORCID,Lee Soo Jung²^ORCID,Kim Sujeong¹^ORCID,Lee Jong-Myung¹^ORCID,Hong Dae Gy³^ORCID

Affiliation:

1. Department of Allergy and Clinical Immunology, School of Medicine, Kyungpook National University, Daegu, Korea.

2. Department of Oncology, School of Medicine, Kyungpook National University, Daegu, Korea.

3. Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, Korea.

Funder

Kyungpook National University Hospital

Publisher

The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al

Subject

Pulmonary and Respiratory Medicine,Immunology,Immunology and Allergy

Link

https://e-aair.org/pdf/10.4168/aair.2020.12.6.1046

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Desensitization Update: Key Concepts and Mechanisms;Current Treatment Options in Allergy;2023-12-27

2. Effectiveness of Carboplatin-Prescreening Intradermal Skin Tests to Reduce Unanticipated Immediate Hypersensitivity Reactions: A Comparative Study;The Journal of Allergy and Clinical Immunology: In Practice;2023-12

3. Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study;Medicine;2022-11-11

4. Successful nedaplatin desensitization therapy in a patient with platinum-sensitive recurrent ovarian cancer: A case report and literature review;Gynecologic Oncology Reports;2022-10

5. Desensitization Protocol to Carboplatin: A Technical Report;Cureus;2022-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3